Aging
Navigate
Research Paper|Volume 10, Issue 8|pp 1964—1976

Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis

Junming Bi1,2, Hongwei Liu1,2, Zijian Cai1,2, Wei Dong1,2, Ning Jiang1,2, Meihua Yang1,2, Jian Huang1,2, Tianxin Lin1,2
  • 1Department of Urology, Sun Yat-Sen Memorial Hospital Sun Yat-Sen University, Guangzhou, PR China
  • 2Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital Sun Yat-Sen University, Guangzhou, PR China

* * Equal contribution

Received: June 1, 2018Accepted: August 6, 2018Published: August 9, 2018

Copyright: © 2018 Bi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Circ-BPTF (hsa_circ_0000799) is a novel circular RNA derived from BPTF exons. Although BPTF is a well-studied predecessor gene, the characteristics and functions of circ-BPTF have not yet been reported. Here, we show that expression of circ-BPTF is increased in bladder cancer (BCa) tissues and cell lines compared with noncancerous tissues and cell lines. Consistently, BCa patients with higher expression levels of circ-BPTF were found to have higher tumor grades and poorer prognosis. Functionally, knockdown of circ-BPTF inhibited tumor progression in vitro and in vivo. Mechanistically, a target microRNA of circ-BPTF was confirmed to be miR-31-5p, and miR-31-5p mimics partially reversed the effect of circ-BPTF. Furthermore, RAB27A was predicted and shown to be a target of miR-31-5p, and circ-BPTF attenuated the anti-oncogenic effect of miR-31-5p and consequently enhanced RAB27A expression. In summary, our findings reveal that circ-BPTF promotes BCa progression through the miR-31-5p/RAB27A axis, suggesting that circ-BPTF may be a potential target for BCa treatment.